Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
March 26th 2010
 
 
  Do you know someone who would be interested in receiving their own copy of this eNewsletter? If so, why not send this newsletter on to them and suggest they subscribe?
   
  Findings from DiabetesE
  Fifth National Report (Innove)
   
  The organisation and delivery of diabetes services in the UK
  This factsheet from NHS Diabetes summarises the findings of a scoping exercise by (NHS Diabetes)
   
  Commissioning Guides
  (NHS Diabetes)
   
  Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting
  The present review has the aim to discuss the importance of glycaemic control for future cardiovascular events starting from the in-hospital setting and continuing to long-term management based on available literature and recently updated international guidelines (Reviews in Endocrine & Metabolic Disorders)
   
  Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
  Using algorithms to shut off the insulin pump when hypoglycemia is predicted, it is possible to prevent hypoglycemia on 75% of nights (84% of events) when it would otherwise be predicted to occur (Diabetes Care)
   
  Use of continuous glucose monitoring in young children with type 1 diabetes: implications for behavioral research
  CGM may be particularly useful in young children who often experience more glucose variability. Data obtained via CGM are richer and more detailed than traditional SMBG data and allow for analyses to link blood glucose with behavior (Pediatric Diabetes)
   
  Screening and diagnosing diabetes in optometrists' practices: an evaluation of perceptions, attitudes and beliefs
  Optometrists are willing to carry out capillary blood glucose tests, provided that the scheme is simple, is supported by other health care professionals and is properly funded (Practical Diabetes International)
   
  Influence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In Vivo
  Together, these data suggest that insulin's inhibitory effect on alpha cell glucagon release is in part mediated at the level of the VMH under both normoglycemic and hypoglycemic conditions (Diabetes)
   
  Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
  The combination of insulin with pioglitazone, a TZD, reduces glycoated hemoglobin (HbA1c) by 0.6%–2.1%. The higher the HbA1c baseline the larger the therapeutic reduction of HbA1c (Vascular Health and Risk Management)
   
  Prevalence of Diabetes among Men and Women in China
  These results indicate that diabetes has become a major public health problem in China and that strategies aimed at the prevention and treatment of diabetes are needed. (NEJM)
   
  Oramed Announces Completion of Pivotal Phase 2b Clinical Trials of it's Oral Insulin Capsule for Type 2 Diabetes
  The Phase 2b trial is a randomized, double-blind, placebo-controlled, multi-centered study, that primary evaluated the safety, and tolerability of Oramed's oral insulin delivery technology (PR Newswire)
   
  Onglyza (Saxagliptin) And Extended Release Metformin For The Treatment Of Type 2 Diabetes
  U.S. Food And Drug Administration Accepts New Drug Application For Once-Daily Fixed Dose Combination Of Onglyza (Saxagliptin) And Extended Release Metformin For The Treatment Of Type 2 Diabetes Mellitus In Adults (PharmaLive)
   
  Diamyd granted Orphan Drug Designation in the US
  The Orphan Drug Designation is granted for rhGAD65, the active ingredient of Diamyd®, for the treatment of type 1 diabetes with residual beta cell function (Diamyd)
   
  New form of insulin can be inhaled rather than injected
  Scientists today described a new ultra-rapid acting mealtime insulin (AFREZZA) that is orally inhaled for absorption via the lung (Genetic Engineering & Biotechnology News)
   
  No more daily jabs or endless blood tests
  The 30-minute op to give diabetics their lives back (Daily Mail, UK)
   
 
  
© Copyright Glycosmedia Partnership